文献速递心脏核医学神经核医学

18F-FDOPA-PET/CT评估IPD患者心肌交感神经支配的可行性研究

Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.
PubMed 文献 · J Nucl Cardiol · 2021-01-10

单示踪剂单次显像可行。

要点

  • 18F-FDOPA单示踪剂单次显像可同时评估纹状体与心肌交感功能。
  • IPD伴自主神经功能障碍患者心肌18F-FDOPA摄取显著降低。
  • MwMR与直立试验收缩压下降负相关,或反映交感功能障碍程度。

核心结论

  • 在晚期IPD患者中,使用18F-FDOPA进行单示踪剂、单次显像评估纹状体与心脏交感功能障碍是可行的。
  • 伴交感功能障碍的IPD患者心肌18F-FDOPA摄取显著降低。

研究设计与样本

  • 纳入28例自主功能试验异常且纹状体多巴胺能功能障碍的IPD患者(平均年龄58.18±8.25岁,18例男性)。
  • 同一时段行心脏PET/CT(静脉注射185-259MBq 18F-FDOPA后40分钟)和脑PET/CT(注射后60分钟),并于左心室心肌、各壁及纵隔勾画ROI定量。
  • 患者与对照分别随访26.93±5.43个月和37.91±8.63个月。

主要发现

  • 随访期间自主功能试验异常的20例患者中9例功能恶化,边缘异常的8例中2例恶化。

临床怎么用

  • 对伴自主神经功能障碍的IPD患者,可考虑用18F-FDOPA-PET/CT单次显像同时评估纹状体与心肌交感神经支配。
  • MwMR可作为反映心肌交感功能障碍程度的定量指标,并与收缩压下降相关。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dysfunction and denervation of myocardial nor-adrenergic sympathetic neurons has been documented in IPD patients with dysautonomia. The aim of this study was to evaluate the feasibility of single tracer imaging of myocardial sympathetic and cerebral striatal involvement in these patients. METHODS: Twenty-two controls (mean-age 59.09 ± 12.39 years, 15 men) with no clinical autonomic-dysfunction and normal striatal-uptake in 18F-FDOPA-PET/CT; and 28 patients (mean-age 58.18 ± 8.25 years, 18 men) with autonomic-dysfunction (in Autonomic Function Tests) and striatal dopaminergic-dysfunction were enrolled. Both cardiac-PET/CT (40 minutes post IV-injection of 185-259MBq 18F-FDOPA) and Brain-PET/CT (60 minutes post-IV) were acquired in same session. ROIs were drawn over the entire left ventricular myocardium, individual walls and mediastinum for quantification. Patients and controls were followed-up for 26.93 ± 5.43 months and 37.91 ± 8.63 months, respectively. RESULTS: Striatal and myocardial-parameters were significantly lower in patients compared to controls; with Myocardium/mediastinal ratio (MwMR) yielding the area-under-the-curve of .941 (P < .001). MwMR correlated negatively with the drop in systolic blood pressure (SBP) during AFTs {Pearson-coefficient (-).565, P = .002}. Mean MwMR in patients with abnormal-AFTs was significantly lower than patients with borderline-AFTs (1.39 ± .12 vs 1.55 ± .10; P = .002). 9/20 patients with abnormal-AFTs showed functional worsening during follow-up, compared to 2/8 with borderline-AFTs. CONCLUSION: Single tracer, single session imaging of striatal and cardiac sympathetic dysfunction in patients with advanced IPD is feasible with use of 18F-FDOPA. Significantly reduced 18F-FDOPA uptake is seen in the myocardium of the IPD patients with sympathetic dysfunction.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Goyal H, Sharma A, Patel C, et al. Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients. J Nucl Cardiol. 2021. PMID: 33426586. doi:10.1007/s12350-020-02474-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。